Reported about 15 hours ago
Billionaire investor Stanley Druckenmiller has significantly increased his investment in Natera, a clinical genetic testing company, by 80%, making it his largest U.S. stock holding. Natera specializes in noninvasive DNA testing for prenatal and cancer diagnostics and has seen its stock price soar, more than doubling this year. Following strong quarterly results, analysts have raised their price targets for the company, citing its ongoing growth and strong performance in women's health and oncology.
Source: YAHOO